|
SE8004002L
(sv)
|
1980-05-29 |
1981-11-30 |
Arvidsson Folke Lars Erik |
Terapeutiskt anvendbara tetralinderivat
|
|
IL65501A
(en)
|
1981-05-08 |
1986-04-29 |
Astra Laekemedel Ab |
1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
|
|
DE3718317A1
(de)
|
1986-12-10 |
1988-06-16 |
Bayer Ag |
Substituierte basische 2-aminotetraline
|
|
DE3719924A1
(de)
|
1986-12-22 |
1988-06-30 |
Bayer Ag |
8-substituierte 2-aminotetraline
|
|
DE69032725T2
(de)
|
1989-05-31 |
1999-04-08 |
Pharmacia & Upjohn Co., Kalamazoo, Mich. |
ZNS-wirksame 8-Heterocyclyl-2-aminotetralin Derivate
|
|
FR2659853A1
(fr)
|
1990-03-22 |
1991-09-27 |
Midy Spa |
Utilisation de derives 2-aminotetraliniques pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale.
|
|
EP0738149B1
(en)
|
1994-01-10 |
2006-11-29 |
Teva Pharmaceutical Industries, Ltd. |
1-aminoindan derivatives and compositions thereof
|
|
EP1083889B1
(en)
|
1998-06-01 |
2003-12-10 |
Ortho-McNeil Pharmaceutical, Inc. |
Tetrahydronaphtalene compounds and their use for the treatment of neurodegenerative diseases
|
|
DE19834044A1
(de)
|
1998-07-29 |
2000-02-03 |
Bayer Ag |
Neue substituierte Pyrazolderivate
|
|
DE19834047A1
(de)
|
1998-07-29 |
2000-02-03 |
Bayer Ag |
Substituierte Pyrazolderivate
|
|
GB9827467D0
(en)
|
1998-12-15 |
1999-02-10 |
Zeneca Ltd |
Chemical compounds
|
|
DE19943635A1
(de)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
|
AR031176A1
(es)
|
2000-11-22 |
2003-09-10 |
Bayer Ag |
Nuevos derivados de pirazolpiridina sustituidos con piridina
|
|
DE10109858A1
(de)
|
2001-03-01 |
2002-09-05 |
Bayer Ag |
Neuartige halogensubstituierte Aminodicarbonsäurederivate
|
|
DE10109861A1
(de)
|
2001-03-01 |
2002-09-05 |
Bayer Ag |
Neuartige seitenkettenhalogenierte Aminodicarbonsäurederivate
|
|
DE10109859A1
(de)
|
2001-03-01 |
2002-09-05 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate
|
|
DE10110750A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
|
DE10110749A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Substituierte Aminodicarbonsäurederivate
|
|
DE10220570A1
(de)
|
2002-05-08 |
2003-11-20 |
Bayer Ag |
Carbamat-substituierte Pyrazolopyridine
|
|
JP2006522634A
(ja)
|
2003-04-14 |
2006-10-05 |
ベクトゥラ・リミテッド |
投与効率を向上させるデバイス及び製薬組成
|
|
US20050032873A1
(en)
|
2003-07-30 |
2005-02-10 |
Wyeth |
3-Amino chroman and 2-amino tetralin derivatives
|
|
US7803951B2
(en)
|
2005-03-30 |
2010-09-28 |
Merck Sharp & Dohme Corp. |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
|
DE102005050377A1
(de)
|
2005-10-21 |
2007-04-26 |
Bayer Healthcare Ag |
Heterocyclische Verbindungen und ihre Verwendung
|
|
WO2009023669A1
(en)
|
2007-08-13 |
2009-02-19 |
Janssen Pharmaceutica N.V. |
Substituted 5,6,7,8-tetrahydroquinoline derivatives, compositions, and methods of use thereof
|
|
KR20100059952A
(ko)
|
2007-09-06 |
2010-06-04 |
머크 샤프 앤드 돔 코포레이션 |
가용성 구아닐레이트 사이클라제 활성제
|
|
JP2011185957A
(ja)
|
2008-07-04 |
2011-09-22 |
Sharp Corp |
偏光板、表示装置及びその製造方法
|
|
WO2010021882A2
(en)
|
2008-08-19 |
2010-02-25 |
Janssen Pharmaceutica Nv |
Cold menthol receptor antagonists
|
|
DE102010020553A1
(de)
|
2010-05-14 |
2011-11-17 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte 8-Alkoxy-2-aminotetralin-Derivate und ihre Verwendung
|
|
DE102010021637A1
(de)
|
2010-05-26 |
2011-12-01 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung
|
|
EP2687210A1
(de)
|
2010-06-25 |
2014-01-22 |
Bayer Intellectual Property GmbH |
Verwendung von Stimulatoren und Aktivatoren der löslichen Guanylatzyklase zur Behandlung von Sichelzellanämie und Konservierung von Blutersatzstoffen
|
|
PE20130779A1
(es)
|
2010-07-09 |
2013-06-21 |
Bayer Ip Gmbh |
Pirimidinas y triazinas condensadas y su uso
|
|
DE102010040233A1
(de)
|
2010-09-03 |
2012-03-08 |
Bayer Schering Pharma Aktiengesellschaft |
Bicyclische Aza-Heterocyclen und ihre Verwendung
|
|
DE102010043379A1
(de)
|
2010-11-04 |
2012-05-10 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung
|
|
JP5715713B2
(ja)
|
2011-03-10 |
2015-05-13 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
可溶性グアニル酸シクラーゼ活性化因子
|
|
AU2012295802B2
(en)
|
2011-08-12 |
2017-03-30 |
Nissan Chemical Industries, Ltd. |
Tricyclic heterocyclic compounds and JAK inhibitors
|
|
US9290440B2
(en)
|
2012-04-16 |
2016-03-22 |
Toa Eiyo Ltd. |
Bicyclic compound
|
|
KR102137517B1
(ko)
|
2012-07-20 |
2020-07-24 |
바이엘 파마 악티엔게젤샤프트 |
신규 5-아미노테트라히드로퀴놀린-2-카르복실산 및 그의 용도
|
|
ES2603262T3
(es)
|
2012-07-20 |
2017-02-24 |
Bayer Pharma Aktiengesellschaft |
Ácidos aminoindano-carboxílicos y aminotetralin-carboxílicos sustituidos y su uso
|
|
US9624214B2
(en)
|
2012-11-05 |
2017-04-18 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
|
GB201305825D0
(en)
|
2013-03-28 |
2013-05-15 |
Vectura Ltd |
New use
|
|
WO2019081456A1
(en)
|
2017-10-24 |
2019-05-02 |
Bayer Aktiengesellschaft |
USE OF SGC ACTIVATORS AND STIMULATORS COMPRISING A BETA2 SUBUNIT
|
|
US20230183181A1
(en)
|
2020-05-20 |
2023-06-15 |
Bayer Aktiengesellschaft |
Process of preparing butyl-(5s)-5-({2-[4-(butoxycarbonyl)phenyl]ethyl}[2-(2-{[3-chloro-4'-(trifluoromethyl)[biphenyl]-4-yl]methoxy}phenyl)ethyl]amino)-5,6,7,8-tetrahydroquinoline-2-carboxylate
|
|
TW202342012A
(zh)
|
2021-12-29 |
2023-11-01 |
德商拜耳廠股份有限公司 |
製備用作醫藥活性化合物的（５ｓ）－｛［２－（４－羧基苯基）乙基］［２－（２－｛［３－氯－４＇－（三氟甲基）聯苯－４－基］甲氧基｝苯基）乙基］胺基｝－５，６，７，８－四氫喹啉－２－羧酸及其結晶形式之方法
|
|
CN118765199A
(zh)
|
2021-12-29 |
2024-10-11 |
拜耳股份公司 |
心肺病症的治疗
|
|
US20250281480A1
(en)
|
2021-12-29 |
2025-09-11 |
Bayer Aktiengesellschaft |
Pharmaceutical dry powder inhalation formulation
|